Saturday 17 October 2026
Export EDSA’s income statement to Excel — free account
Edesa Biotech, Inc.
EDSA Healthcare Biotechnology
In the quarter to June 2026, EPS fell 140.0% and free cash flow fell 81.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.57
0.10
−3.75%
Follow EDSA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
2.70 | 4.67 | 16.51 | 10.60 | |
Current Ratio |
2.76 | 4.76 | 16.82 | 10.67 | |
Net Debt/EBITDA |
1.88 | 2.34 | 5.20 | 4.42 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.57 | 0.48 | 0.93 | 0.77 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.15 | 0.16 | 0.13 | 0.15 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.34) | (0.24) | (0.26) | (0.30) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.34) | (0.24) | (0.26) | (0.30) | |
Cash per Share |
1.15 | 1.17 | 1.51 | 1.90 | |
Shareholders Equity per Share |
0.98 | 1.19 | 1.75 | 2.19 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.98 | 1.19 | 1.75 | 2.19 | |
Free Cash Flow |
(3.08) | (2.02) | (2.09) | (1.72) | |
Working Capital |
6.87 | 8.23 | 11.96 | 10.43 | |
Net Current Asset Value |
6.87 | 8.23 | 11.96 | 10.43 | |
| Other line items | |||||
Average Receivables |
0.26 | 0.30 | 0.39 | 0.46 | |
Average Payables |
2.29 | 1.55 | 1.33 | 1.45 | |
Average Assets |
13.76 | 14.42 | 9.44 | 8.67 | |
Average Common Equity |
2.65 | 4.09 | 2.97 | 2.59 |
Columns are period end dates